This paper by Theo Manolikas (Principal, Blue Matter) and Michelle Lock (Sr. VP and Head of Europe and International, Acceleron Pharma) outlines 6 key models that biotech companies can use to guide the development of their European operations.
Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.